Volume 13, Number 8—August 2007
Research
Occupational Risks during a Monkeypox Outbreak, Wisconsin, 2003
Donita R. Croft*1
, Mark J. Sotir*†, Carl J. Williams*2, James J. Kazmierczak*, Mark V. Wegner*, Darren Rausch‡, Mary Beth Graham§, Seth L. Foldy§¶, Mat Wolters¶, Inger K. Damon†, Kevin L. Karem†, and Jeffrey P. Davis*
, Mark J. Sotir*†, Carl J. Williams*2, James J. Kazmierczak*, Mark V. Wegner*, Darren Rausch‡, Mary Beth Graham§, Seth L. Foldy§¶, Mat Wolters¶, Inger K. Damon†, Kevin L. Karem†, and Jeffrey P. Davis*Table 2
Medical data for veterinary facility cohort members during outbreak of monkeypox virus infections, by case status, Wisconsin, 2003*
| Medical history | |||||
|---|---|---|---|---|---|
| Vaccinia vaccination | 7/17 (41) | 23/57 (40) | 0.95§ | 1.0 | 0.4–2.4 |
| Atopic dermatitis | 1/17 (6) | 4/57 (7) | 1.0 | 0.9 | 0.1–5.2 |
| Seasonal allergies | 7/17 (41) | 21/57 (37) | 0.75§ | 1.2 | 0.5–2.7 |
| Open sores at time of prairie dog visit | 5/17 (29) | 9/57 (16) | 0.28 | 1.8 | 0.8–4.3 |
| Upper respiratory infection at time of prairie dog visit | 3/17 (18) | 3/57 (5) | 0.13 | 2.4 | 1.0–6.1 |
| Antihistamine use at time of prairie dog visit | 4/17 (24) | 3/57 (5) | 0.04 | 3.0 | 1.3–6.6 |
*RR, relative risk; CI, confidence interval; UND, undeterminable; NA, not accurate.
†Denominators vary according to total no. persons with work roles appropriate to the exposure; e.g., a receptionist would not be expected to administer subcutaneous fluids.
‡Fisher exact 2-tail test unless otherwise indicated.
§Mantel-Haenszel test.
